First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Shares Shorted: Short Interest Down 50.2% in September

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 9,470 shares, a drop of 50.2% from the September 15th total of 19,031 shares. Based on an average daily volume of 468,724 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in FTXH. MinichMacGregor Wealth Management LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at about $968,000. Nilsine Partners LLC lifted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after purchasing an additional 937 shares in the last quarter. Compass Financial Management LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the second quarter valued at approximately $29,000. Finally, Vivaldi Capital Management LP boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after buying an additional 1,741 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 2.1%

NASDAQ FTXH traded up $0.86 during mid-day trading on Wednesday, hitting $41.29. The company’s stock had a trading volume of 32,672 shares, compared to its average volume of 233,511. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45. The company’s 50 day simple moving average is $41.07 and its 200 day simple moving average is $37.70. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $28.85 and a twelve month high of $43.52.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Thursday, September 24th were paid a $0.0113 dividend. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.1%. This is a negative change from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date of this dividend was Thursday, September 24th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.